Role of pharmacogenetics in public health and clinical health care: a SWOT analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of pharmacogenetics in public health and clinical health care: a SWOT analysis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 24, Issue 12, Pages 1651-1657
Publisher
Springer Nature
Online
2016-09-01
DOI
10.1038/ejhg.2016.114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Next generation sequencing: implications in personalized medicine and pharmacogenomics
- (2016) Bahareh Rabbani et al. Molecular BioSystems
- Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription
- (2015) Ritika Kapoor et al. Pharmacogenetics and Genomics
- Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols
- (2015) David S. Lehmann et al. Pharmacogenetics and Genomics
- Atomoxetine pharmacogenetics: associations with pharmacokinetics, treatment response and tolerability
- (2015) Jacob T Brown et al. PHARMACOGENOMICS
- New Oral Anticoagulants vs. Warfarin Treatment: No Need for Pharmacogenomics?
- (2014) W L Baker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype
- (2014) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
- (2014) Kelly Caudle et al. CURRENT DRUG METABOLISM
- Genetics and genomics in Thailand: challenges and opportunities
- (2014) Vorasuk Shotelersuk et al. Molecular Genetics & Genomic Medicine
- Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand
- (2013) Waranya Rattanavipapong et al. EPILEPSIA
- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
- (2013) Stephen E. Kimmel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
- (2013) Danielle Welter et al. NUCLEIC ACIDS RESEARCH
- Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand
- (2013) Somsak Tiamkao et al. International Journal of Clinical Pharmacy
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
- (2012) D. Dong et al. NEUROLOGY
- The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing
- (2012) Sze Ling Chan et al. PHARMACOGENOMICS
- Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
- (2011) Ratchadaporn Somkrua et al. BMC Medical Genetics
- CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention
- (2011) Guillaume Paré et al. Circulation-Cardiovascular Interventions
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
- (2011) L. B. Ramsey et al. GENOME RESEARCH
- The gain-of-function variant allele CYP2C19*17: a double-edged sword between thrombosis and bleeding in clopidogrel-treated patients
- (2011) Y. LI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Translational aspects of genetic factors in the prediction of drug response variability: a case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia
- (2011) S L Chan et al. PHARMACOGENOMICS JOURNAL
- Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain
- (2010) Diana Nieves Calatrava et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Clinical assessment incorporating a personal genome
- (2010) Euan A Ashley et al. LANCET
- Common risk allele in aromatic antiepileptic-drug induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese
- (2010) Shuen-Iu Hung et al. PHARMACOGENOMICS
- Irinotecan pharmacogenomics
- (2010) Sharon Marsh et al. PHARMACOGENOMICS
- Role of pharmacogenomics in drug discovery and development
- (2009) C Adithan et al. INDIAN JOURNAL OF PHARMACOLOGY
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
- (2008) Bruce R Schackman et al. AIDS
- A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
- (2008) G. M. Cooper et al. BLOOD
- Should HLA‐B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?
- (2008) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Genetic Determinants of Response to Warfarin during Initial Anticoagulation
- (2008) Ute I. Schwarz et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started